1.Effect of Fetal Sex Hormone on the Development of Alzheimer’s Disease in Woman:A Cross-Sectional Study Using 2D/4D Digit Length Ratio
Tae Uk KANG ; Young Min LEE ; Je Min PARK ; Byung Dae LEE ; Eun soo MOON ; Hee Jeong JEONG ; Soo Yeon KIM ; Kang Yoon LEE ; Hwa gyu SUH ; Young-In CHUNG
Journal of Korean Geriatric Psychiatry 2020;24(2):99-102
Objective:
The purpose of this study is to investigate an association between sex-hormone exposure during fetal period and the development of Alzheimer’s disease (AD).
Methods:
Twenty four AD patients and 25 normal controls were included from Memory Impairment Clinic of Pusan National University Hospital in Korea. Subjects are measured the ratio of the length of the second to the fourth digit (2D/4D) to estimate fetal sex-hormone exposure. Analysis of covariance was used to investigate an association between fetal sex-hormone exposure and the development of AD after adjusting age, education level, Korean Mini-Mental Status Examination and head circumference.
Results:
We found that the females with AD had significantly lower 2D/4D ratios than the female controls. In the females withAD, the 2D/4D ratios in the left hand was 0.021 and 0.017 in the right hand compared with the controls.
Conclusion
Our findings suggest that the development of AD in female may be related with higher testosterone and lower es-trogen exposure during fetal period.
2.2014–2017 Nationwide Bariatric and Metabolic Surgery Report in Korea
In Gyu KWON ; Jong Won KIM ; Gil Ho KANG ; Dong Wook KIM ; Sung Geun KIM ; Seong Min KIM ; Seong Soo KIM ; Yong Jin KIM ; Wook KIM ; Jong Han KIM ; Ji Heon KIM ; Jin Jo KIM ; Ho Goon KIM ; Seung Wan RYU ; Do Joong PARK ; Dong Jin PARK ; Sung Soo PARK ; Yoon Chan PARK ; Joong Min PARK ; Ji Yeon PARK ; Kyung Won SEO ; Byoung Jo SUH ; Soo Min AHN ; Hye Seong AHN ; Moon Won YOO ; Sang Kuon LEE ; Han Hong LEE ; Hyuk Joon LEE ; Kyong Hwa JUN ; Kyung Ook JUNG ; Minyoung CHO ; Seung Ho CHOI ; Man ho HA ; Tae Kyung HA ; Sang Moon HAN ; Sang Uk HAN ; Yoon Seok HEO ; Woo Jin HYUNG ; Joo Ho LEE ;
Journal of Metabolic and Bariatric Surgery 2018;7(2):49-53
PURPOSE: The information committee of the Korean Society for Metabolic and Bariatric Surgery (KSMBS) performed the nationwide survey of bariatric and metabolic operations to report IFSO (International Federation for the Surgery of Obesity and Metabolic Disorders) worldwide survey annually. This study aimed to report the trends of bariatric and metabolic surgery in Korea in 2014–2017. MATERIALS AND METHODS: We analyzed the accumulated nationwide survey data conducted for annual ISFO survey from 2014 to 2017. Trends such as the number of operations by hospital type and the number of operations by surgical method were analyzed. RESULTS: The number of operations has decreased sharply in 2015 comparing to 2014 (913⇒550). The number of operations performed in private hospitals dropped sharply from 529 to 250, 198, and 103 cases. The number of revisional surgeries increased to 223 in 2015. The primary surgery number fell from 757 in 2014 to 327 in 2015. In primary surgery, sleeve gastrectomy was gradually increased from 2014 to 143 (18.9%), 105 (32.1%), 167 (47.2%) and 200 (56.3%) and became the most frequently performed surgery. On the other hand, the incidence of adjustable gastric band decreased gradually from 439 (58.0%) to 117 (35.8%), 112 (31.6%) and 59 (16.6%). CONCLUSION: The overall number of obesity metabolic operations has decreased since 2014, especially the number of adjustable gastric band, and the number of operations in private hospitals declined sharply. On the other hand, the number of operations in university hospitals did not change much, and the number of sleeve gastrectomy increased.
Bariatric Surgery
;
Gastrectomy
;
Hand
;
Hospitals, Private
;
Hospitals, University
;
Incidence
;
Korea
;
Methods
;
Obesity
3.A Case of Toenail Onychomycosis Due to Aspergillus sydowii Infection.
You Bum SONG ; Jun Gyu SONG ; Moo Kyu SUH ; Gyoung Yim HA ; Jin Hwa CHOI
Korean Journal of Medical Mycology 2015;20(1):6-12
Onychomycosis is caused by dermatophytes usually, but some species of nondermatophytic molds and yeasts are also associated with invasion of nails. Aspergillus sydowii is a nondermatophytic mold which is opportunistic filamentous fungus in all environments. We report a case of onychomycosis caused by A. sydowii in a 65-year-old male. The patient showed yellowish discoloration with hyperkeratotic change on the distal and lateral portion of both great toenails. Direct microscopic examination of scraping on the potassium hydroxide preparation revealed dichotomous septate hyphae and repeated cultures on Sabouraud dextrose agar showed the same blue green velvety colonies. Biseriate phialides that cover entire vesicle with conidial structure resembling Penicillium were shown in the slide culture. The DNA sequence of internal transcribed spacer (ITS) region of clinical sample was 99% match to that of A. sydowii strain XWSFJJ1 (GenBank accession number FJ461692). We confirmed A. sydowii by KOH mount, colony, light microscopic morphology and DNA sequence analysis. The patient was treated with 250 mg oral terbinafine daily and topical 5% amorolfine nail lacquer for 3 months.
Agar
;
Aged
;
Arthrodermataceae
;
Aspergillus*
;
Base Sequence
;
Fungi
;
Glucose
;
Humans
;
Hyphae
;
Lacquer
;
Male
;
Nails*
;
Onychomycosis*
;
Penicillium
;
Potassium
;
Sequence Analysis, DNA
;
Yeasts
4.Relationships of Coagulation Factor XIII Activity with Cell-Type and Stage of Non-Small Cell Lung Cancer.
Seung Heon LEE ; In Bum SUH ; Eun Joo LEE ; Gyu Young HUR ; Sung Yong LEE ; Sang Yeub LEE ; Chol SHIN ; Jae Jeong SHIM ; Kwang Ho IN ; Kyung Ho KANG ; Se Hwa YOO ; Je Hyeong KIM
Yonsei Medical Journal 2013;54(6):1394-1399
PURPOSE: Factor XIII (FXIII), a thrombin-activated plasma transglutaminase zymogen, is involved in cancer development and progression through a triggered coagulation pathway. The aim of this study was to examine whether FXIII activity levels differed in non-small cell lung cancer (NSCLC) patients according to histological types and TNM stage when compared with healthy subjects. MATERIALS AND METHODS: Twenty-eight NSCLC patients and 28 normal controls who had been individually age-, gender-, body mass index-, smoking status-, and smoking amount-matched were enrolled: 13 adenocarcinomas, 11 squamous cell carcinomas, and four undifferentiated NSCLCs; four stage I, two stage II, 12 stage III, and 10 stage IV NSCLCs. FXIII activity was measured using fluorescence-based protein arrays. RESULTS: The median FXIII activity level of the NSCLC group [24.2 Loewy U/mL, interquartile range (IQR) 14.9-40.4 Loewy U/mL] was significantly higher than that of the healthy group (17.5 Loewy U/mL, IQR 12.6-26.4 Loewy U/mL) (p=0.01). There were no differences in FXIII activity between adenocarcinoma (median 18.6 Loewy U/mL) and squamous cell carcinoma (median 28.7 Loewy U/mL). NSCLC stage significantly influenced FXIII activity (p=0.02). The FXIII activity of patients with stage III NSCLC (median 27.3 Loewy U/mL, IQR 19.3-40.5 Loewy U/mL) was significantly higher than those of patients with stage I or II (median 14.0 Loewy U/mL, IQR 13.1-23.1 Loewy U/mL, p=0.04). FXIII activity was negatively correlated with aPTT in NSCLC patients (r=-0.38, p=0.04). CONCLUSION: Patients with advanced-stage NSCLC exhibited higher coagulation FXIII activity than healthy controls and early-stage NSCLC patients.
Aged
;
Carcinoma, Non-Small-Cell Lung/*metabolism/*pathology
;
Case-Control Studies
;
Factor XIII/*metabolism
;
Female
;
Humans
;
Lung Neoplasms/*metabolism/*pathology
;
Male
;
Middle Aged
;
Neoplasm Staging
5.Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication.
Young Hwa KIM ; Hwa Kyung CHUNG ; Kee Duk PARK ; Kyoung Gyu CHOI ; Seung Min KIM ; Il Nam SUNWOO ; Young Chul CHOI ; Jeong Geun LIM ; Kwang Woo LEE ; Kwang Kuk KIM ; Dong Kuk LEE ; In Soo JOO ; Ki Han KWON ; Seok Beom GWON ; Jae Hyeon PARK ; Dae Seong KIM ; Seung Hyun KIM ; Woo Kyung KIM ; Bum Chun SUH ; Sang Beom KIM ; Nam Hee KIM ; Eun Hee SOHN ; Ok Joon KIM ; Hyun Sook KIM ; Jung Hee CHO ; Sa Yoon KANG ; Chan Ik PARK ; Jiyoung OH ; Jong Hyu SHIN ; Ki Wha CHUNG ; Byung Ok CHOI
Journal of Clinical Neurology 2012;8(2):139-145
BACKGROUND AND PURPOSE: Charcot-Marie-Tooth disease (CMT) type 1A (CMT1A) is the demyelinating form of CMT that is significantly associated with PMP22 duplication. Some studies have found that the disease-related disabilities of these patients are correlated with their compound muscle action potentials (CMAPs), while others have suggested that they are related to the nerve conduction velocities. In the present study, we investigated the correlations between the disease-related disabilities and the electrophysiological values in a large cohort of Korean CMT1A patients. METHODS: We analyzed 167 CMT1A patients of Korean origin with PMP22 duplication using clinical and electrophysiological assessments, including the CMT neuropathy score and the functional disability scale. RESULTS: Clinical motor disabilities were significantly correlated with the CMAPs but not the motor nerve conduction velocities (MNCVs). Moreover, the observed sensory impairments matched the corresponding reductions in the sensory nerve action potentials (SNAPs) but not with slowing of the sensory nerve conduction velocities (SNCVs). In addition, CMAPs were strongly correlated with the disease duration but not with the age at onset. The terminal latency index did not differ between CMT1A patients and healthy controls. CONCLUSIONS: In CMT1A patients, disease-related disabilities such as muscle wasting and sensory impairment were strongly correlated with CMAPs and SNAPs but not with the MNCVs or SNCVs. Therefore, we suggest that the clinical disabilities of CMT patients are determined by the extent of axonal dysfunction.
Action Potentials
;
Axons
;
Charcot-Marie-Tooth Disease
;
Cohort Studies
;
Humans
;
Muscles
;
Neural Conduction
6.Erratum: Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication.
Young Hwa KIM ; Hwa Kyung CHUNG ; Kee Duk PARK ; Kyoung Gyu CHOI ; Seung Min KIM ; Il Nam SUNWOO ; Young Chul CHOI ; Jeong Geun LIM ; Kwang Woo LEE ; Kwang Kuk KIM ; Dong Kuk LEE ; In Soo JOO ; Ki Han KWON ; Seok Beom GWON ; Jae Hyeon PARK ; Dae Seong KIM ; Seung Hyun KIM ; Woo Kyung KIM ; Bum Chun SUH ; Sang Beom KIM ; Nam Hee KIM ; Eun Hee SOHN ; Ok Joon KIM ; Hyun Sook KIM ; Jung Hee CHO ; Sa Yoon KANG ; Chan Ik PARK ; Jiyoung OH ; Jong Hyu SHIN ; Ki Wha CHUNG ; Byung Ok CHOI
Journal of Clinical Neurology 2012;8(3):241-241
The publisher wishes to apologize for incorrectly displaying the author (Seok Beom Gwon) name. We correct his name from Seok Beom Gwon to Seok Beom Kwon.
7.Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?.
Yoon Kyung PARK ; Kang Mo KIM ; Young Joo LEE ; Ki Hun KIM ; Sung Gyu LEE ; Danbi LEE ; Ju Hyun SHIM ; Young Suk LIM ; Han Chu LEE ; Young Hwa CHUNG ; Yung Sang LEE ; Dong Jin SUH
Journal of Korean Medical Science 2011;26(2):214-221
Hepatitis B virus X (HBx) protein has been known to play an important role in development of hepatocellular carcinoma (HCC). The aim of this study is to find out whether HBx protein expression affects antiproliferative effect of an epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor and a MEK inhibitor in HepG2 and Huh-7 cell lines. We established HepG2 and Huh-7 cells transfected stably with HBx gene. HBx protein expression increased pERK and pAkt expression as well as beta-catenin activity in both cells. Gefitinib (EGFR-TK inhibitor) inhibited pERK and pAkt expression and beta-catenin activity in both cells. Selumetinib (MEK inhibitor) reduced pERK level and beta-catenin activity but pAkt expression was rather elevated by selumetinib in these cells. Reduction of pERK levels was much stronger with selumetinib than gefitinib in both cells. The antiproliferative efficacy of selumetinib was more potent than that of gefitinib. However, the antiproliferative effect of gefitinib, as well as selumetinib, was not different between cell lines with or without HBx expression. Signal pathway activation by HBx might not be strong enough to attenuate the antiproliferative effect of EGFR-TK inhibitor. Future experiments are needed to understand the role of HBx protein expression in HCC treatment using molecular targeting agent.
Animals
;
Antineoplastic Agents/*pharmacology
;
Benzimidazoles/*pharmacology
;
Carcinoma, Hepatocellular/*metabolism
;
Cell Line, Tumor/drug effects
;
Cell Proliferation
;
Extracellular Signal-Regulated MAP Kinases/metabolism
;
Humans
;
Liver Neoplasms/*metabolism
;
Mitogen-Activated Protein Kinase Kinases/*antagonists & inhibitors
;
Protein Kinase Inhibitors/*pharmacology
;
Proto-Oncogene Proteins c-akt
;
Quinazolines/*pharmacology
;
Receptor, Epidermal Growth Factor/antagonists & inhibitors
;
Signal Transduction/*drug effects
;
Trans-Activators/*metabolism
;
beta Catenin/metabolism
8.Two Cases of Streptococcal Toxic Shock Syndrome Caused by Streptococcus agalactiae and Streptococcus dysagalactiae.
Young Sun SUH ; Yun Hong CHEON ; Min Kyo KIM ; Jong Hwa AHN ; Sang Su LEE ; Min Hee LIM ; Byung Hoon KIM ; Sunjoo KIM ; Myung Je CHO ; In Gyu BAE
Infection and Chemotherapy 2011;43(5):429-431
Streptococcal toxic shock syndrome (STSS) is an acute, progressive illness that manifests with fever, hypotension, and accelerated multi-organ failure. It is usually caused by Group A Streptococcus (Streptococcus pyogenes). STSS due to non-group A streptococci is rare, but its incidence has recently increased. We report here on two cases of STSS caused by Group B Streptococcus (Streptococcus agalactiae) and Group G Streptococcus (Streptococcus dysagalactiae).
Fever
;
Hypotension
;
Incidence
;
Shock, Septic
;
Streptococcus
;
Streptococcus agalactiae
9.Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis.
Jeong Ik PARK ; Kun Moo CHOI ; Sung Gyu LEE ; Shin HWANG ; Ki Hun KIM ; Chul Soo AHN ; Deok Bog MOON ; Young Hwa CHUNG ; Yung Sang LEE ; Dong Jin SUH
The Korean Journal of Hepatology 2007;13(4):543-555
BACKGROUND AND AIMS: Hepatitis C virus (HCV)-associated cirrhosis is an increasingly frequent indication for liver transplantation (LT). However, HCV recurrence is universal and this immediately occurs following LT, which endangers both the graft and patient survival. We investigated the frequency of posttransplant recurrence of HCV infection and the patient-graft survival, and we analyzed the responses to ribavirin and interferon therapy in the patients with recurrent HCV infection after living donor liver transplantation (LDLT). METHODS: We retrospectively reviewed the clinical outcomes of 39 HCV-associated cirrhosis patients who underwent LDLT at Asan Medical Center between August 1992 and June 2006. In this study, the diagnosis of recurrent HCV was made on the basis of increased transaminases and serum HCV RNA levels greater than 10 million IU/mL because protocol liver biopsy was not performed. RESULTS: HCV recurrence was seen in 26 of the 39 LDLT patients (66.7%). 86.7% of recurrence occurred within the first postoperative year. Antiviral treatment was used for all patients with recurrence of HCV. None of the 10 patients receiving ribavirin alone and 9 of 16 patients who received combination therapy with pegylated interferon alpha-2a plus ribavirin became HCV RNA negative and they remained persistently negative during the median follow-up of 24.9 months. Our data indicates that there is no significant factor influencing HCV recurrence except for the recipient's age. The 2-year patient survival for the HCV patients with HCC and those patients without HCC were 81.2% and 81.3%, respectively (P=0.85) and the 2-year graft survival rates were 81.2% and 68.2%, respectively (P=0.29). No patient died from HCV recurrence during the follow-up period. CONCLUSIONS: Combination therapy with ribavirin and interferon appears to improve the outcome of recurrent HCV infected patients after LDLT.
Adult
;
Aged
;
Antiviral Agents/therapeutic use
;
Combined Modality Therapy
;
Female
;
Graft Survival
;
Hepacivirus/drug effects/isolation & purification
;
Hepatitis C, Chronic/complications/diagnosis/*drug therapy
;
Humans
;
Interferon Alfa-2a/therapeutic use
;
Liver Cirrhosis/mortality/*surgery/*virology
;
Liver Neoplasms/mortality
;
*Liver Transplantation
;
Living Donors
;
Male
;
Middle Aged
;
Polyethylene Glycols/therapeutic use
;
Recurrence
;
Retrospective Studies
;
Ribavirin/therapeutic use
;
Severity of Illness Index
;
Treatment Outcome
10.A Case of Left Iliac Vein Thrombosis with May-Thurner Syndrome.
Gang Jee KO ; Hong Seog SEO ; Myung Gyu KIM ; Jung Yup KIM ; Soon Yong SUH ; Hwa Jung SUNG ; Sang Woo PARK ; Chang Gyu PARK ; Dong Joo OH
Korean Journal of Hematology 2004;39(2):113-117
Iliac vein compression syndrome (May-Thurner syndrome) is caused by compression of the left iliac vein against the fifth lumbar vertebra by the right iliac artery, resulting in impaired venous return and left iliofemoral thrombosis. We experienced a case of a 68-year-old woman who showed sudden left lower extremity edema. By the Doppler sonogram, deep vein thrombosis of left lower extremity was detected. It was involved only left side and extended to iliac vein level. In the venogram, spur like projection was noticed on left iliac vein. Through endovascular thrombectomy, thrombolysis and angioplasty, venous return was completely restored. We report a case of May-Thurner syndrome who was treated with various endovascular management successfully.
Aged
;
Angioplasty
;
Edema
;
Female
;
Humans
;
Iliac Artery
;
Iliac Vein*
;
Lower Extremity
;
May-Thurner Syndrome*
;
Spine
;
Thrombectomy
;
Thrombosis*
;
Venous Thrombosis

Result Analysis
Print
Save
E-mail